Home/PRM Pharma/Peter R. Kowey, MD

PR

Peter R. Kowey, MD

Head, Cardiovascular Products

Therapeutic Areas

Cardiovascular Rare Disease Metabolic

PRM Pharma Pipeline

Drug	Indication	Phase
HemiClor (hydrochlorothiazide 6.25 mg)	Hypertension in adults	Approved

Leadership Team at PRM Pharma

Joseph T. McDevitt

President and CEO

Melvin Sharoky, MD

Head, Corporate and Scientific Affairs

Deborah Maroko, MD

Head, Medical Affairs

View full PRM Pharma profile